Rolls-Royce Holdings plc (LON:RR – Get Free Report) insider Helen McCabe bought 17 shares of the company’s stock in a transaction dated Monday, June 9th. The stock was bought at an average price of GBX 876 ($11.93) per share, for a total transaction of £148.92 ($202.75).
Helen McCabe also recently made the following trade(s):
- On Wednesday, March 12th, Helen McCabe sold 400,659 shares of Rolls-Royce Holdings plc stock. The shares were sold at an average price of GBX 767 ($10.44), for a total value of £3,073,054.53 ($4,183,872.74).
Rolls-Royce Holdings plc Stock Up 1.5%
RR stock opened at GBX 893.40 ($12.16) on Friday. The stock’s 50 day moving average is GBX 782.75 and its 200-day moving average is GBX 690.56. The firm has a market capitalization of £76.62 billion, a PE ratio of 32.57, a P/E/G ratio of 0.55 and a beta of 1.82. Rolls-Royce Holdings plc has a twelve month low of GBX 196.45 ($2.67) and a twelve month high of GBX 537.20 ($7.31).
Analyst Ratings Changes
About Rolls-Royce Holdings plc
Rolls-Royce Holdings plc develops and delivers complex power and propulsion solutions for air, sea, and land in the United Kingdom and internationally. The company operates through four segments: Civil Aerospace, Defence, Power Systems, and New Markets. The Civil Aerospace segment develops, manufactures, markets, and sells aero engines for large commercial aircraft, regional jet, and business aviation markets, as well as provides aftermarket services.
Featured Articles
- Five stocks we like better than Rolls-Royce Holdings plc
- What is Put Option Volume?
- Ignore the Noise—Samsara Stock Is Still a Strong Buy
- Asset Allocation Strategies in Volatile Markets
- 3 Stocks Set to Double—And There’s Still Time to Buy
- Retail Stocks Investing, Explained
- Analysts Can’t Get Enough of These Little-Known Biopharma Stocks
Receive News & Ratings for Rolls-Royce Holdings plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Rolls-Royce Holdings plc and related companies with MarketBeat.com's FREE daily email newsletter.